Ailanthus altissima, commonly known as the 'tree of heaven,' is used in traditional medicine in many parts of Asia including China to treat cold and gastric diseases. Extracts of A. altissima, have demonstrated anti-proliferative 1) and central nervous depressant activities.
7)
Asthma is one of the most common diseases characterized by airway hyper-responsiveness (AHR) associated with elevated serum IgE and bronchial inflammation. In bronchial asthma, various factors result in infiltration of mast cells, eosionphils and T H 2 lymphocytes into the lesions with a downstream mediator. 8) Measurements of eicosanoids and their metabolites in bronchoalveolar lavage fluid (BALF) after inhaled allergen challenge of asthmatics suggest that resident mast cells, infiltrating eosinophils, basophils and macrophages are responsible for leukotrienes (LTs) and prostaglandins (PGs) in the early and late bronchoconstrictor responses. 9, 10) Eicosanoids are inflammatory mediators that are biosynthesized in many cell types by cyclooxygenases (COX) and lipoxygenases (LOX). They are strongly associated with inflammatory disorders, acute as well as chronic inflammation. The inhibition of eicosanoid production is one of the important therapeutic strategies in various inflammatory diseases. Among the eicosanoid generating enzymes, COX-2 was found to be essential for the production of PGs in inflammatory sites. 11) LTs produced by 5-LOX also have biological properties that would be expected for molecules that participate in the pathogenesis of bronchial asthma. 12) Therefore, the dual inhibition of COX-2/5-LOX is believed to be the ideal treatment for allergic diseases and asthma. 13) Although many biological activities of A. altissima were reported, the anti-asthmatic activity of A. altissima has not been reported. In the present study, we describe a new biological function of A. altissima for the arachidonic cascade metabolism enzymes such as COX-2 and 5-LOX along with the potential for use in the treatment of asthma.
MATERIALS AND METHODS

Plant Material
The leaf and branch of A. altissima were collected in July 2004 in Daejeon, Korea. This plant material was authenticated by one of the authors (KH Bae) and a voucher specimen has been deposited in the Herbarium of College of Pharmacy, Chungnam National University under the registration number CNU 923. The dried sample (1 kg) was extracted in ethanol (5 l) by refluxing for 24 h twice to give 212 g of an extract and used throughout this study.
Preparation of Bone Marrow-Derived Mast Cells (BMMC) Bone marrow cells from male BALB/c mice (Hyochang Science, Daegu, Korea) were cultured for up to 10 weeks in 50% enriched medium (RPMI 1640 containing 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 0.1 mM nonessential amino acids, and 10% fetal calf serum) and 50% WEHI-3 cell conditioned medium as a source of IL-3. After 3 weeks Ͼ98% of the cells were found to be BMMC when checked by the previously described procedure. 14) For the activation of BMMC, c-kit ligand (KL), LPS (Difco, Detroit, MI, U.S.A.) and IL-10 were obtained by their expression in baculovirus, as described previously. 15, 16) PGD 2 Production and COX-2 Activity BMMC at a cell density of 5ϫ10 5 cells/ml in enriched medium were preincubated with aspirin (1 mg/ml) for 2 h to irreversibly inactivate preexisting COX-1. After washing, cells were acti- Western Blot Analysis After activation with KL, IL-10 and LPS, BMMC were washed once with 10 mM PBS (pH 7.4) containing 150 mM NaCl and lysed in PBS containing 0.1% SDS and 10 mM b-mercaptoethanol at 1ϫ10 7 cells/ml. The lysate (2ϫ10 5 cells equivalent) was applied to 10% SDS-polyacrylamide gels. After running the gel, the proteins were transferred in 20% methanol, 25 mmol/l Tris, and 192 mmol/l glycine to a nitrocellulose membrane. The membrane was blocked with 5% non-fat dry milk in TTBS (25 mmol/l Tris-HCl, 150 mmol/l NaCl, and 0.2% and probed with the COX-2 antibody (Cayman Chemical). After incubation for 1 h followed by washing three times, the membranes were incubated for 1 h with a secondary HRPconjugated antibody. The protein bands were visualized using an ECL system (Amersham Biosciences, Piscataway, NJ, U.S.A.).
Effect of EAa on 5-LOX Activity BMMC suspended in enriched medium at cell density of 1ϫ10 6 cells/ml were pretreated with EAa for 30 min at 37°C. After 15 min of stimulation with KL (100 ng/ml), the supernatants were isolated for further analysis by EIA. LTC 4 was determined using an enzyme immunoassay kit (Cayman Chemical) according to manufacturer's instruction. Under the conditions employed, the amount of LTC 4 . Briefly, after harvesting supernatant, cells were lysed in the same volume of medium by freeze and thaw three times. Twenty-five microliters of the BMMC lysate or supernatant was mixed with 50 ml of b-HEX substrate solution (1.3 mg/ml p-nitrophenyl-2-acetamido-2-deoxy-b-D-glucopyranoside in 100 mM sodium citrate, pH 4.5) in each well of 96-well plates and then incubated at 37°C for 60 min. The reaction was stopped by adding 175 ml of 0.2 M Glycin/NaOH (pH 10.7). The absorbance at 405 nm was measured in a microplate reader. The percentage of b-HEX released into the supernatant was calculated by the following formula: [S/(SϩP)]ϫ100, where S and P are the b-HEX contents of supernatant and cell pellet, respectively.
Preparation of cDNA and RT-PCR Total RNA from mouse lung was extracted with TRI ZOL ® reagent (Invitrogen, Carlsbad, CA, U.S.A.) according to the manufacturer's instructions. RT-PCR was carried out using RNA PCR kit (Takara, Shiga, Japan) by thermal cycler (GeneAmp PCR system 2400, Perkin-Elmer, Norwalk, CT, U.S.A.). One microgram of total RNA from each sample was used as template for RT reaction using 2.5 pmol oligo (dT) 20 primers and 5 U of Avian Myeloblastosis Virus (AMV) reverse transcriptase in 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 1 U/ml RNase inhibitor and 1 mM dNTP mixture. Two microliters of RT product was used for PCR. PCR was carried out in a final volume of 20 ml containing 1 mM MgCl 2 , 1X PCR buffer, 1 mM dNTP mixture, 1 U Takara Taq DNA polymerase, 0.2 mM each primer. Amplifications were carried out using a thermal cycler with the following profile: 5 min at 94°C before the first cycle, 30 s for denaturation at 94°C, 30 s for primer annealing, 30 s for extension at 72°C, and 5 min at 72°C after the last cycle. Primer sequences and PCR product sizes were as follows: eotaxin, 5Ј-CCA AGG ACT TGG CTT CAT GTA G-3Ј and 5Ј-ATT CTG GCT TGG CAT GGT AGC-3Ј, 495 bp, 25 cycles; IL-4, 5Ј-ACG GCA CAG AGC TAT TGA TG-3Ј and 5Ј-ATG GTG GCT CAG TAC TAC GA-3Ј, 454 bp, 35 cycles; IL-13, 5Ј-ACA GCT CCC TGG TTC TCT CA-3Ј and 5Ј-CCA GCA AAG TCT GAT GTG AG-3Ј, 500 bp, 35 cycles. Actin-specific primers (5Ј-CAC CCG CCA CCA GTT CGC CA-3Ј and 5Ј-CAG GTC CCG GCC AGC CAG GT-3Ј, 574 bp, 25 cycles) were used as the positive comparative controls. After amplification, 10 ml of each reaction mixture was analyzed by 1.2% agarose gel electrophoresis, and the bands were visualized with ethidium bromide staining.
Allergen Sensitization, Challenge and EAa Treatment Six weeks old female BALB/c were sensitized by intraperitoneal (i.p.) administration on days 0, 7, and 14 with 100 mg/ml of OVA in PBS mixed with equal volumes of alum (Pierce Biotechnology, Rockford, IL, U.S.A.) as an adjuvant in a total volume of 200 ml. On days 22 and 24, mice were exposed to aerosolized OVA (1% OVA in PBS) or PBS for 1 h. EAa or dexamethasone (DEX, Sigma) was treated for 7 times orally at every 12 h from one day before the first challenge to 1 h before the second challenge. The challenge and treatment protocol is shown in Fig. 1 .
BALF Preparation and Eosinophil Counting
Eighteen hours after the last aerosol challenge, mice were sacrificed. To obtain BALF, mice were anesthetized, a tracheal cannula was inserted in each mouse via a midcervical incision, and the airway of each mouse was lavaged three times with 1.5 ml of PBS. BALF was immediately centrifuged (2 min, 4°C, 160ϫg). After removing the supernatant, the cells were resuspended in 0.5 ml of PBS. Ten microliters of the BALF was used for total leukocytes with hemocytometer. The re- Fig. 1 . Immunization Protocol All mice were sensitized by intraperitoneally (i.p.) with 200 ml (100 ml of OVA and 100 ml of alum) on days 0, 7 and 14. The mice were then exposed to aerosolized OVA (1% OVA in PBS) or PBS for 1 h on days 22 and 24. The mice were orally administrated with EAa or dexamethasone (DEX) for 7 times at 12 h intervals from days 21 to 23. At day 24, 18 h after the last aerosol, BALF and lung were obtained. maining samples were cytospined for routine Diff-Quick staining (Sysmex, Kobe, Japan) and the number of eosinophils was determined by counting more than 200 cells in a microscopic field. The eosinophil % was expressed as a percentage of the total leukocytes. The data is represented as an arithmetic meanϮS.D. (nϭ6).
Statistical Analysis All determinations for PGD 2 , LTC 4 generation, and b-HEX release were triplicate and the 50% inhibitory concentration was obtained by linear regression analysis. All values were represented as arithmetic meanϮ S.D. One-way ANOVA was used to determine the statistical significance.
RESULTS AND DISCUSSION
BMMC exhibit biphasic PGD 2 synthetic responses over time, as well as COX-1-dependent immediate and COX-2-dependent delayed responses. The immediate PGD 2 generation occurring within 2 h is associated with the coupling of COX-1 with the delayed PGD 2 generation, which is observed after several hours of culturing (during 2-10 h). This is associated with the de novo induction and function of COX-2 after stimulation with particular combinations of cytokines and LPS. 16) As shown in Fig. 2A , COX-2-dependent PGD 2 generation was inhibited in a dose-dependent manner in the presence of EAa when the BMMC were stimulated with KL, IL-10, and LPS with an IC 50 value of approximately 214.6 mg/ml. However, EAa did not affect the expression of COX-2 protein (Fig. 2B) . In order to determine if EAa inhibits the delayed phase PGD 2 generation via direct inhibition of COX-2 activity, the enzyme activity was measured. EAa inhibited the COX-2 dependent PGD 2 generation in a concentration-dependent manner with an IC 50 value of 47.4 mg/ml (Fig. 2C) . These results clearly show that the reduced PGD 2 production by EAa in the BMMC was due to the inhibition of COX-2 enzyme activity. For COX-1 dependent PGD 2 generation, EAa inhibited PGD 2 production in a dose-dependent manner with IC 50 value of 131.66 mg/ml (data not shown).
BMMC have been used in our laboratory for screening 5-LOX inhibitors because the immediate LTC 4 generation elicited by the IgE-dependent or cytokines occurs in BMMC via 5-LOX. 17) Therefore, the inhibitory activity of EAa on the generation of LTC 4 in the BMMC was examined. Figure  3 shows that the BMMC stimulated with KL for 15 min produced approximately 2.0 ng/ml of LTC 4 , and preincubation of the BMMC with EAa resulted in the dose-dependent suppression of LTC 4 generation with an IC 50 value of 25.7 mg/ml.
Mast cells are involved in allergic disorders by virtue of their ability to be activated through Fc e RI or cytokine receptors. Activated mast cells release a number of biologically active molecules, including histamine, serotonin, proteoglycans and neutral proteases. Among these molecules, histamine is one of the most important chemical mediators in the pathologic allergic reaction.
18) The release of histamine bears a close parallel to that of b-HEX, which is one of degranulation marker. Therefore, the inhibitory activity of EAa on the degranulation reaction in the BMMC was examined. As shown in Fig. 4 , EAa caused the dose-dependent inhibition of b-HEX release with an IC 50 value of 27.3 mg/ml. Under the conditions employed, b-HEX was released about 33-35% without the pretreatment of EAa.
On allergen challenge of airways, the mast cells release preformed and synthesized mediators. Among those mediators, histamine, LTs, and PGs whose increased production has been demonstrated in asthma have significant effects on the eosinophil activation and chemotaxis. [19] [20] [21] [22] [23] Because EAa inhibited PGD 2 and LTC 4 production as well as b-HEX release in BMMC, these results have led us to determine the biological activity of EAa in in vivo animal model. The number of total leukocytes in the BALF obtained from the PBS- challenged group was 0.88Ϯ0.21ϫ10 5 cells, but relatively few eosinophils was detected in this group. On the other hand, the total number of leukocytes (6.2Ϯ1.5ϫ10 5 ) and eosinophils (3.84Ϯ0.04ϫ10 5 ) in the BALF of the OVA-challenged lung tissues was significantly higher compared with the PBS-challenged group (data not shown). When 100-400 mg/kg of EAa was administered orally to the mice 7 times, the number of eosinophils was weakly reduced in a dose-dependent manner (Fig. 5) . Under the same conditions, DEX (5 mg/kg) significantly inhibited the recruitment of eosinophils. EAa was orally administered to mice up to 800 g/kg for 14 d to determine the acute toxicity. No apparent toxicity including dead animals and the changes was observed (data not shown), indicating that this plant material by oral administration may be used safely in human at moderate doses.
Clinical and experimental investigations have reported a strong correlation between the presence of CD4 ϩ T H 2 cells and disease severity, suggesting an integral role for these cells in the pathophysiology of asthma. 24, 25) Among the T H 2 cytokines, high levels of IL-4 and IL-13 were produced at in an asthmatic lung and are believed to be the key regulators of many of hallmark features of disease. [26] [27] [28] [29] Accumulated studies have also suggested an important role of eotaxin in allergic inflammatory disease, especially in the early of eosinophil recruitment after allergen challenge. [30] [31] [32] Therefore, the effect of EAa on the mRNA expression level of the eotaxin and T H 2 cytokines was examined because EAa reduced the number of infiltrated eosinophils in the BALF. As shown in Fig. 6 , the expression of eotaxin and T H 2 cytokine mRNA was very weak and almost undetectable, respectively in the normal lung tissue whereas those mRNA were induced in the OVA-challenged mice compared with the PBS-challenged mice. However, pretreatment of OVA-challenged mice with EAa reduced the transcription levels of eotaxin, IL-4, and IL-13. DEX also inhibited mRNA expression of those genes from the OVA-challenged lung. Since IL-5 is an important factor in recruiting eosinophils in allergic tissues, the effect of EAa on the mRNA expression level of IL-5 was examined. Pretreating the OVA-challenged mice with EAa did not effectively inhibit IL-5 mRNA expression (Fig. 6) , which indicating IL-5 in conjunction with eotaxin may cause a marked increase in eosinophils. Fujitani et al. reported that PGD 2 overproduction increased IL-4, IL-5 and eotaxin in BALF of transgenic mice overexpressing human PGD synthase. 33) In addition, deletion of PGD 2 receptor in mice markedly reduced the pulmonary eosinophilia and AHR, which was accompanied by reduced levels of the T H 2 cytokines. 34) Furthermore, it was shown that LTC 4 could stimulate eotaxin production by IL-13-treated fibroblasts, thereby indirectly inducing eosinophilic inflammation. 35) Overproduction of eicosanoids in the airway asthma may cause an increase in the level of T H 2 cytokines and an eotaxin accompanied by the enhanced accumulation of eosinophils in the lung. Therefore, the reduction of infiltrated eosinophils in the lung by EAa may occur in part via the inhibition of eicosanoid generation, which reduced directly or indirectly the level of eotaxin and T H 2 cytokines.
In conclusion, the present paper shows that A. altissima has anti-inflammatory activities in in vitro as well as in vivo OVA-induced lung. This study suggests that some herbal medicines such as A. altissima may be useful for treating inflammation related disorders such as asthma. Mice were sensitized with OVA in the presence of adjuvant alum and were subsequently challenged with PBS or OVA challenge. EAa (or DEX) was orally pretreated 7 times. Eighteen hours after the second aerosol challenge, mice were sacrificed and lungs were taken. Total RNA from lungs of mice was subjected to RT-PCR analysis.
